Alertness Aid Tablet
NDC Package 68016-680-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Alertness Aid (caffeine) tablets is adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hourschildren under 12 years: do not use. This formulation utilizes a tablet delivery system. Marketed by Chain Drug Consortium, this product is identified by NDC 68016-680 and is authorized under FDA application M011.

Identification & Billing

NDC Package Code
68016-680-40
Package Description
5 BLISTER PACK in 1 CARTON / 8 TABLET in 1 BLISTER PACK
Product Code
68016-680
11-Digit Billing Format
68016068040
RxNorm Crosswalk
RxCUI: 198520 - caffeine 200 MG Oral Tablet

Clinical Specifications

Proprietary Name
Alertness Aid
Non-Proprietary Name
Caffeine
Substance Name
Caffeine
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CAFFEINE 200 mg/1
Pharmacologic Class
Usage Information
adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hourschildren under 12 years: do not use

Regulatory & Marketing

Labeler Name
Chain Drug Consortium
Product Type
Human Otc Drug
FDA Application #
M011
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-21-1996
End Marketing Date
07-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68016-680). Click a package code to view its specific billing and regulatory data.

68016-680-16
2 BLISTER PACK in 1 CARTON / 8 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68016-680-40 identifies a specific commercial package of 5 blister pack in 1 carton / 8 tablet in 1 blister pack of Alertness Aid, a human over the counter drug labeled by Chain Drug Consortium. This tablet is formulated for oral use and contains caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Consortium on November 21, 1996.

How is this Chain Drug Consortium product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016068040. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68016-680-40
11-Digit CMS (5-4-2)
68016-0680-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.